ask="2.80"
ask_size="200"
average_daily_volume="513940"
bid="2.30"
bid_size="500"
book_value="3.56"
change="+0.03"
change_from_200_day_moving_average="-2.03"
change_from_50_day_moving_average="0.39"
change_from_52_week_high="-6.59"
change_From_52_week_low="0.76"
change_in_percent="+1.10%"
close="2.76"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.03"
ebitda="-31.76M"
eps_estimate_current_year="-1.34"
eps_estimate_next_quarter="-0.43"
eps_estimate_next_year="-1.33"
ex_dividend_date="N/A"
float_shares="8386000"
high="2.85"
high_52_weeks="9.35"
last_trade_date="3/1/2017"
last_trade_price="2.76"
last_trade_size="259"
last_trade_time="4:00pm"
low="2.67"
low_52_weeks="2.00"
market_capitalization="43.21M"
moving_average_200_day="4.79"
moving_average_50_day="2.37"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.63"
open="2.77"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-42.32%"
percent_change_from_50_day_moving_average="+16.64%"
percent_change_from_52_week_high="-70.48%"
percent_change_from_52_week_low="+38.00%"
previous_close="2.73"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.77"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15656000"
short_ratio="0.64"
stock_exchange="NGM"
symbol="NVLS"
volume="282634"
weeks_range_52="2.00 - 9.35"
